Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Alcidion Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Aging Populations Will Fuel Digital Healthcare In Australia And UK
Key Takeaways Accelerating demand for digital healthcare and AI-powered solutions is expanding Alcidion's market, contractual opportunities, and recurring revenue potential. Product innovation and operational momentum boost competitive positioning, customer retention, and prospects for sustained profitability growth.
View narrative
AU$0.12
FV
10.8% undervalued
intrinsic discount
12.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
3 days ago
author updated this narrative
NATCO Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Anticipated Revlimid Allocation Could Shape Future Amid Profit Margin Concerns
Key Takeaways Substantial future growth expected from Revlimid allocation, semaglutide launch, and first-to-file ANDA drug launches, enhancing revenue and earnings. Strategic focus on cash utilization and growth in Crop Health Sciences and acquisitions may improve revenue base and long-term earnings stability.
View narrative
₹972.09
FV
6.6% undervalued
intrinsic discount
-10.08%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
51
users have followed this narrative
27 days ago
author updated this narrative
Synthomer
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Sustainable Specialty Polymers Will Unlock New Global Opportunities
Key Takeaways Focus on specialty polymers, cost-reduction, and global diversification positions Synthomer to achieve better margins, stable earnings, and long-term growth in sustainable markets. Expansion into eco-friendly products and high-growth regions leverages regulatory trends and urbanization, supporting multi-year revenue and margin improvement.
View narrative
UK£1.57
FV
60.6% undervalued
intrinsic discount
4.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
BFF Bank
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Reinforced Sales Teams And Legal Strategies Will Improve Future Operations
Key Takeaways Strengthened sales leadership and enhanced legal processes are expected to boost loan growth, revenue, net margins, and reduce provisioning risks. New deposit activities in Greece and regulatory changes could optimize capital, increasing capital ratios and supporting earnings growth.
View narrative
€11.34
FV
0.5% overvalued
intrinsic discount
3.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
Updated
narrative
Domain Holdings Australia
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Investments In AI And Platinum Edge Will Drive Future Potential Despite Valuation Concerns
Key Takeaways Strategic investments in technology and AI aim to boost future revenue and operating margins through product innovation and enhanced user engagement. Partnership with Nine and premium product adoption enhance branding and pricing power, supporting stable revenue and earnings growth.
View narrative
AU$4.16
FV
6.2% overvalued
intrinsic discount
6.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
10 days ago
author updated this narrative
Bank Hapoalim B.M
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Modern Digital Banking In Israel Will Unlock Future Efficiency
Key Takeaways Ongoing digitization and operational modernization are driving cost efficiencies, margin expansion, and higher non-interest revenues tied to changing consumer behavior. Improved credit quality and robust lending growth position the bank for sustained profitability and flexibility in shareholder returns amid favorable economic conditions.
View narrative
₪70.75
FV
7.6% undervalued
intrinsic discount
5.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
IRB-Brasil Resseguros
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Risk Management And ESG Integration Will Support Stability Amid Revenue Decline
Key Takeaways Advanced risk management and actuarial processes are expected to improve underwriting decisions, enhancing financial stability and net margins. Strategic focus on Non-Life international expansion and improved capital allocation is likely to drive premium growth, profitability, and overall earnings.
View narrative
R$52.57
FV
11.8% undervalued
intrinsic discount
-6.47%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
12 days ago
author updated this narrative
NNIT
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Integration And New Systems In 2024 Will Streamline Operations And Lower Costs
Key Takeaways Strategic initiatives, such as ERP integration and restructuring, are set to enhance operational efficiency, profitability, and market competitiveness. Expansion in key sectors and strong customer satisfaction indicate steady growth, with organic growth targets outpacing the market.
View narrative
DKK 80.00
FV
18.5% undervalued
intrinsic discount
6.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Banco BBVA Argentina
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Argentina's Expected 55% GDP Growth Will Open Up Banking Opportunities
Key Takeaways Economic recovery in Argentina and digital shifts enhance BBVA Argentina's revenue and net margins through increased banking demand and operational efficiency. Strategic focus on market share and asset quality, along with treasury management, stabilizes net interest margins and boosts profitability.
View narrative
AR$10.02k
FV
26.9% undervalued
intrinsic discount
18.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
25 days ago
author updated this narrative
Value any company in seconds
Popular companies